Format

Send to

Choose Destination
Curr Atheroscler Rep. 2012 Oct;14(5):450-9. doi: 10.1007/s11883-012-0274-8.

Making a difference: monocyte heterogeneity in cardiovascular disease.

Author information

1
Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Simches Research Building, 185 Cambridge St., Boston, MA 02114, USA. hilgendorf.ingo@mgh.harvard.edu

Abstract

Monocytes are frequently described as bone marrow-derived precursors of macrophages. Although many studies support this view, we now appreciate that monocytes neither develop exclusively in the bone marrow nor give rise to all macrophages and dendritic cells. In addition to differentiating to specific leukocyte populations, monocytes, as monocytes, are functionally and ontogenically heterogeneous. In this review we will focus on the development and activity of monocytes and their subsets in mice (Ly-6 C(high/low)) and humans (CD14(+/dim/-) CD16(+/-)) in the context of atherosclerosis and its complications.

PMID:
22847772
PMCID:
PMC3436972
DOI:
10.1007/s11883-012-0274-8
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center